Midgard Science
SP

Stira Pharmaceuticals

Fairfield, NJ, United States stirapharma.com From their website, Nov 2026

  • GMP

Work here? Claim this listing

About

Stira Pharmaceuticals is a U.S.-based CDMO in Fairfield, New Jersey focused on sterile injectable drug products. It provides analytical, development, and cGMP manufacturing services for small molecules, peptides, oligonucleotides, and large molecules including biosimilars, for clinical and commercial programs.

Services

  • Contract analytical services

    Provides deep analytical expertise for peptides, small molecules, oligonucleotides, and biosimilars.

  • Analytical testing

    Offers standalone analytical testing for small molecules, peptides, biologics, biosimilars, and oligonucleotides.

  • Analytical method development and validation

    Develops, validates, and transfers analytical methods for APIs, excipients, and drug products.

  • Preformulation

    Performs pharmaceutical profiling and preformulation studies for molecules.

  • Extractables and leachables studies

    Conducts extractables and leachables evaluations for packaging, container-closure, and label migration studies.

  • In vitro permeability testing (IVPT)

    Provides IVPT method development and validation.

  • In vitro release testing (IVRT)

    Provides IVRT method development and validation and drug release profiling.

  • In vitro biowaiver studies

    Offers in vitro biowaiver studies.

7 more services
  • Stability testing
  • Clinical manufacturing
  • Commercial manufacturing
  • Microbiology testing
  • Regulatory support
  • Product development
  • Cell-based assays

Capabilities

Assays and studies
  • Oligonucleotides
  • Peptides
  • Small molecules
  • Stability studies
  • Cell-based assays
  • Analytical development
14 more
  • Advanced structural and physicochemical characterization
  • Commercial testing and release
  • In vitro biowaiver studies
  • Iron complex product sameness testing
  • Nitrosamine testing
  • Small molecule and peptide testing and sameness studies
  • Oligonucleotides (ASO) testing
  • Biosimilar product testing
  • Drug-device combination product testing
  • Extractables and leachables
  • Microbiology (USP/BAM and non-compendial)
  • API characterization
  • Assay testing
  • Related substances testing
Scale and capacity
  • Batch sizes up to ~2000L
  • Three injectable robotic fill-and-finish lines
  • Three aseptic fill-and-finish lines
  • Triple Combi Filling Machine: ~9000 UPH
  • Robotic IV Bag Filling & Sealing Machine: ~1200 UPH
  • Double Combi Filling Machine with Lyophilization: ~6000 or ~12,500 UPH
  • Single-Use Mixing Tanks (50L–2000L)
  • ~88,000 sq.ft. facility

Instruments and platforms

  • HPLC
  • GC-MS
  • LC-MS
  • FT-IR
  • ICP
  • GPC
4 more
  • IC
  • X-RPD
  • DSC
  • TGA

Modalities and species

Modalities
  • Small molecule
  • Peptide
  • Oligonucleotide
  • Biosimilar

Certifications

As the company states them, with the certificate or registry record where there is one.

  • GMPSelf-reported

Details

Type
CRDMO
Address
161 Dwight Place, Fairfield, NJ 07004
Serves
U.S. market

Public records

FDA drug establishment registration
3017224277 · ANALYSIS; MANUFACTURE; PACK source

Similar labs